{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:56:27Z","timestamp":1783392987406,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This study evaluated whether patient support, administered via an electronic device-based app, increased adherence to treatment and lifestyle changes in patients with acute coronary syndrome (ACS) treated with ticagrelor in routine clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients (aged\u2009\u2265\u200918\u00a0years) with diagnosed ACS treated with ticagrelor co-administered with low-dose acetylsalicylic acid were randomized into an active group (with support tool app for medication intake reminders and motivational messages) and a control group (without support tool app), and observed for 48\u00a0weeks (ClinicalTrials.gov Identifier: NCT02615704). Patients were asked to complete the 36-item Short-Form Health Survey (SF-36) and Lifestyle Changes Questionnaire (LSQ), and were assessed for blood pressure and body mass index (BMI) at baseline (visit 1) and at\u00a0the end of the study (visit 2). Medication adherence was measured using the Brilique Adherence Questionnaire (BAQ).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients (<jats:italic>N<\/jats:italic>\u2009=\u2009676) were randomized to an active (<jats:italic>n<\/jats:italic>\u2009=\u2009342) or a\u00a0control (<jats:italic>n<\/jats:italic>\u2009=\u2009334) group. BAQ data were available for 174 patients in the active group and 174 patients in the control group. Over the 48-week period, mean (standard deviation) adherence for the active and control groups was 96.4% (13.2%) and 91.5% (23.1%), respectively (effect of app intervention, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). There were no significant differences in blood pressure and BMI between visits. General improvements in SF-36 and LSQ scores were observed for both groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The patient support tool app was associated with significant improvements in patient-reported treatment adherence compared with a data collection app alone in patients prescribed ticagrelor for ACS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10557-022-07331-1","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T09:03:57Z","timestamp":1650445437000},"page":"729-741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Results from the \u201cMe &amp; My Heart\u201d (eMocial) Study: a Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of Patients with Acute Coronary Syndrome"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5965-8817","authenticated-orcid":false,"given":"Florian","family":"Krackhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"J\u00f6rnten-Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Waliszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Knutsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Niklasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Friedrich","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Alexander","family":"Ohlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tsch\u00f6pe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Theres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"vom Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn W.","family":"Karlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars S.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"7331_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"M Naghavi","year":"2017","unstructured":"Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151\u2013210.","journal-title":"Lancet"},{"key":"7331_CR2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics \u2013 2019 update: a report from the American Heart Association. Circulation. 2019;139:e56-528.","journal-title":"Circulation"},{"key":"7331_CR3","first-page":"e344","volume":"130","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e344-426.","journal-title":"Circulation"},{"key":"7331_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119\u201377.","journal-title":"Eur Heart J"},{"key":"7331_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","volume":"152","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA, et al. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016;152:1243\u201375.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7331_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267\u2013315.","journal-title":"Eur Heart J"},{"key":"7331_CR7","doi-asserted-by":"crossref","unstructured":"Sarajlic P, Simonsson M, Jernberg T, B\u00e4ck M, Hofmann R. Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort study. Eur Heart J Cardiovasc Pharmacother. 2021.","DOI":"10.1093\/ehjcvp\/pvab059"},{"key":"7331_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","volume":"125","author":"SH Naderi","year":"2012","unstructured":"Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125:882\u20137.","journal-title":"Am J Med"},{"key":"7331_CR9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/heartjnl-2014-306754","volume":"101","author":"S Shore","year":"2015","unstructured":"Shore S, Jones PG, Maddox TM, et al. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction. Heart. 2015;101:800\u20137.","journal-title":"Heart"},{"key":"7331_CR10","first-page":"e5389","volume":"11","author":"R Desai","year":"2019","unstructured":"Desai R, Thakkar S, Fong HK, et al. Rising trends in medication non-compliance and associated worsening cardiovascular and cerebrovascular outcomes among hospitalized adults across the United States. Cureus. 2019;11:e5389.","journal-title":"Cureus."},{"key":"7331_CR11","first-page":"35","volume":"7","author":"AO Iuga","year":"2014","unstructured":"Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35\u201344.","journal-title":"Risk Manag Healthc Policy"},{"issue":"suppl 1","key":"7331_CR12","first-page":"P440","volume":"38","author":"X Du","year":"2017","unstructured":"Du X, Jornten-Karlsson M, Xu Y, et al. Ehelp China, a randomised trial evaluating the effect of a smart phone-based patient support tool on treatment duration in patients prescribed rosuvastatin in China. Eur Heart J. 2017;38(suppl 1):P440.","journal-title":"Eur Heart J"},{"key":"7331_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ahj.2016.05.005","volume":"178","author":"N Johnston","year":"2016","unstructured":"Johnston N, Bodegard J, Jerstrom S, et al. Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: a randomized study. Am Heart J. 2016;178:85\u201394.","journal-title":"Am Heart J"},{"key":"7331_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/heartjnl-2018-313479","volume":"105","author":"K Santo","year":"2019","unstructured":"Santo K, Singleton A, Rogers K, et al. Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial. Heart. 2019;105:323\u20139.","journal-title":"Heart"},{"key":"7331_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1001\/jamainternmed.2015.7667","volume":"176","author":"J Thakkar","year":"2016","unstructured":"Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med. 2016;176:340\u20139.","journal-title":"JAMA Intern Med"},{"key":"7331_CR16","unstructured":"Bundesministerium f\u00fcr Gesundheit. Medical Devices Act. https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/3_Downloads\/Gesetze_und_Verordnungen\/GuV\/M\/MPG_englisch.pdf (translation). 2011."},{"key":"7331_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/clc.23254","volume":"42","author":"F Krackhardt","year":"2019","unstructured":"Krackhardt F, Maier LS, Appel KF, et al. Design and rationale for the \u201cMe & My Heart\u201d (eMocial) study: a randomized evaluation of a new smartphone-based support tool to increase therapy adherence of patients with acute coronary syndrome. Clin Cardiol. 2019;42:1054\u201362.","journal-title":"Clin Cardiol"},{"key":"7331_CR18","doi-asserted-by":"publisher","first-page":"e004425","DOI":"10.1136\/bmjopen-2013-004425","volume":"4","author":"KA Fox","year":"2014","unstructured":"Fox KA, Fitzgerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014;4:e004425.","journal-title":"BMJ Open"},{"key":"7331_CR19","volume-title":"User\u2019s Manual for the 36v2\u00ae Health Survey","author":"JE Ware Jr","year":"2007","unstructured":"Ware JE Jr, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User\u2019s Manual for the 36v2\u00ae Health Survey. 2nd ed. Lincoln: Quality Metric Incorporated; 2007.","edition":"2"},{"key":"7331_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"7331_CR21","volume-title":"Usability evaluation in industry","author":"J Brooke","year":"1996","unstructured":"Brooke J. SUS \u2013 a \u201cquick and dirty\u201d usability scale. In: Jordan PW, Thomas B, Weerdmeester BA, McClelland IL, editors. Usability evaluation in industry. London: Taylor & Francis; 1996."},{"key":"7331_CR22","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1093\/eurheartj\/ehu364","volume":"35","author":"K Kolandaivelu","year":"2014","unstructured":"Kolandaivelu K, Leiden BB, O\u2019Gara PT, Bhatt DL. Non-adherence to cardiovascular medications. Eur Heart J. 2014;35:3267\u201376.","journal-title":"Eur Heart J"},{"key":"7331_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2296-14-47","volume":"14","author":"J Furthauer","year":"2013","unstructured":"Furthauer J, Flamm M, Sonnichsen A. Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study. BMC Fam Pract. 2013;14:47.","journal-title":"BMC Fam Pract"},{"key":"7331_CR24","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1161\/CIR.0000000000000579","volume":"138","author":"JW Magnani","year":"2018","unstructured":"Magnani JW, Mujahid MS, Aronow HD, et al. Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: a scientific statement from the American Heart Association. Circulation. 2018;138:e48\u201374.","journal-title":"Circulation"},{"key":"7331_CR25","doi-asserted-by":"publisher","first-page":"e0208303","DOI":"10.1371\/journal.pone.0208303","volume":"13","author":"C Diederichs","year":"2018","unstructured":"Diederichs C, Jordan S, Domanska O, Neuhauser H. Health literacy in men and women with cardiovascular diseases and its association with the use of health care services \u2013 results from the population-based GEDA2014\/2015-EHIS survey in Germany. PLoS One. 2018;13:e0208303.","journal-title":"PLoS One."},{"key":"7331_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12913-017-2162-y","volume":"17","author":"J R\u00f6ttger","year":"2017","unstructured":"R\u00f6ttger J, Bl\u00fcmel M, Busse R. Selective enrollment in Disease Management Programs for coronary heart disease in Germany \u2013 an analysis based on cross-sectional survey and administrative claims data. BMC Health Serv Res. 2017;17:246.","journal-title":"BMC Health Serv Res"},{"key":"7331_CR27","first-page":"1","volume":"1","author":"K Brandy","year":"2017","unstructured":"Brandy K. An overview of the System Usability Scale in library website and system usability testing. J Lib User Experience. 2017;1:1\u201319.","journal-title":"J Lib User Experience"},{"key":"7331_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67\u201374.","journal-title":"Med Care"},{"key":"7331_CR29","doi-asserted-by":"publisher","first-page":"e044987","DOI":"10.1136\/bmjopen-2020-044987","volume":"11","author":"L Foley","year":"2021","unstructured":"Foley L, Larkin J, Lombard-Vance R, et al. Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. 2021;11:e044987.","journal-title":"BMJ Open"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-022-07331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-022-07331-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-022-07331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T10:15:46Z","timestamp":1690971346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-022-07331-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["7331"],"URL":"https:\/\/doi.org\/10.1007\/s10557-022-07331-1","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"28 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and is consistent with the International Council for Harmonisation and Good Clinical Practice, applicable regulatory requirements and the AstraZeneca policy on bioethics. It was approved by the responsible (local) ethics committees. This study was conducted in accordance with paragraph 23b <i>Medizinproduktegesetz<\/i> (German Medical Device Law). All necessary ethics votes were obtained by the participating centers prior to patient recruitment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients provided consent to participate online.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All participating patients provided consent online.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Florian Krackhardt received lecture fees from AstraZeneca; Magnus J\u00f6rnten-Karlsson, Anna Niklasson, Mikael Knutsson, and Bj\u00f6rn W. Karlson were full\u2010time employees of AstraZeneca during the preparation of this manuscript. Carsten Tsch\u00f6pe has received speaker fees and\/or contributions to meetings from Abbott, Abiomed, AstraZeneca, Bayer, Berlin Chemie, Novartis, Pfizer, and Servier, all outside the submitted work. All other authors report no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}